Fate Therapeutics (FATE) Shares Outstanding (Diluted) (2020 - 2026)
Powered by 
Analysis
Fate Therapeutics (FATE) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Fate Therapeutics | 299.79 Mn | 299.79 Mn | - | 120.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 120.40 Mn |
| Mar 31, 2026 | 120.03 Mn |
| Dec 31, 2025 | 118.79 Mn |
| Sep 30, 2025 | 119.00 Mn |
| Jun 30, 2025 | 118.53 Mn |
| Mar 31, 2025 | 118.38 Mn |
| Dec 31, 2024 | 113.69 Mn |
| Sep 30, 2024 | 117.77 Mn |
| Jun 30, 2024 | 117.47 Mn |
| Mar 31, 2024 | 101.10 Mn |
| Dec 31, 2023 | 98.41 Mn |
| Sep 30, 2023 | 98.57 Mn |
| Jun 30, 2023 | 98.40 Mn |
| Mar 31, 2023 | 98.05 Mn |
| Dec 31, 2022 | 96.83 Mn |
| Sep 30, 2022 | 97.02 Mn |
| Jun 30, 2022 | 96.70 Mn |
| Mar 31, 2022 | 96.34 Mn |
| Dec 31, 2021 | 94.75 Mn |
| Sep 30, 2021 | 95.41 Mn |